rs11200014
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | 1.64x risk for breast cancer | |
(A;G) | 1.20x risk for breast cancer | |
(G;G) | common |
Reference | GRCh38 38.1/142 |
Chromosome | 10 |
Position | 121575416 |
Gene | FGFR2 |
is a | snp |
is | mentioned by |
dbSNP | rs11200014 |
dbSNP (classic) | rs11200014 |
ClinGen | rs11200014 |
ebi | rs11200014 |
HLI | rs11200014 |
Exac | rs11200014 |
Gnomad | rs11200014 |
Varsome | rs11200014 |
LitVar | rs11200014 |
Map | rs11200014 |
PheGenI | rs11200014 |
Biobank | rs11200014 |
1000 genomes | rs11200014 |
hgdp | rs11200014 |
ensembl | rs11200014 |
geneview | rs11200014 |
scholar | rs11200014 |
rs11200014 | |
pharmgkb | rs11200014 |
gwascentral | rs11200014 |
openSNP | rs11200014 |
23andMe | rs11200014 |
SNPshot | rs11200014 |
SNPdbe | rs11200014 |
MSV3d | rs11200014 |
GWAS Ctlg | rs11200014 |
GMAF | 0.3379 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
This SNP is basically a proxy for SNP rs1219648, which represents the SNP in the FGFR2 gene with the strongest association with breast cancer. [PMID 17529973]
[PMID 18285324] Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.
[PMID 19223389] FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
[PMID 19497954] Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.
[PMID 19500394] Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.
[PMID 20554749] FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.
[PMID 22965832] Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
[PMID 23124475] Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.